Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomised Controlled Study Demonstrating the Clinical Benefit of Biatain® Ag Relative to Cutimed® Siltec® Sorbact® for the Treatment of Venous Leg Ulcers

NCT05923749 is registered in ClinicalTrials.gov with Coloplast A/S as lead sponsor.

NCT NCT05923749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05923749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomised Controlled Study Demonstrating the Clinical Benefit of Biatain® Ag Relative to Cutimed® Siltec® Sorbact® for the Treatment of Venous Leg Ulcers
Lead sponsor
Coloplast A/S
Phase
Not applicable
Overall status
Completed
Start date
June 29, 2023
Completion date
January 29, 2025
Enrollment
180 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

wound heal